Parexel s'apprête à être acquise par EQT Private Equity et Goldman Sachs Asset Management
06 juil. 2021 14h52 HE
|
Parexel International LLC
BOSTON et DURHAM, Caroline du Nord, 06 juill. 2021 (GLOBE NEWSWIRE) -- Parexel, une organisation de recherche clinique (CRO) de premier plan à l'échelle mondiale axée sur le développement et la...
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
02 juil. 2021 10h33 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Introduces Discussions on Diversity Research to Promote Diversity in Clinical Trials
20 mai 2021 07h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth...
Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report
13 mai 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report
04 mai 2021 09h00 HE
|
Parexel International LLC
BOSTON and Durham, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
04 févr. 2021 07h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C. and FT. MYERS, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve...
Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials
13 janv. 2021 09h00 HE
|
Parexel International LLC
Companies partnering to reduce social determinants of health barriers to clinical trial enrollment BOSTON, DURHAM, N.C. and DALLAS, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Parexel and Signify Health...
Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
11 janv. 2021 06h00 HE
|
Parexel International LLC
Strategic move enhances value and growth for both companiesParexel Informatics to relaunch as Calyx BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of...
Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer
04 janv. 2021 10h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines
14 déc. 2020 12h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...